VECT - VectivBio: Swiss Company With Excellent Data Upcoming Catalysts
2023-04-17 08:00:00 ET
Summary
- VectivBio Holding AG has strong data in rare disease, and the data is better than those from the only approved competitor.
- They have a long cash runway.
- Pivotal data is due in H2 2023.
For further details see:
VectivBio: Swiss Company With Excellent Data, Upcoming Catalysts